Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc. manufactures Acetadote®(acetylcysteine) Injection for acetaminophen overdose. Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury. Acetadote’s 2008 labeling includes post-marketing safety data.
2525 West End Avenue